Oncorus, Inc.
DelistedCIK 1671818fmd_11GA3AJDQX88DW2CRZJR1AGMZNManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Mar 31, 2023, 16 periods
Latest annual · FY2022
Millions- Operating income
- (77)
- Net income
- (77)
- Free cash flow
- (82)
Latest quarter · Q1 FY2023
Millions- Operating income
- (30)
- Net income
- (31)
- Free cash flow
- (18)
Oncorus, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Operating income | -$76.5 million | -$64.8 million | 10-K 2023-03-24 · proof | |
| Net income | -$77.4 million | -$64.8 million | 10-K 2023-03-24 · proof | |
| Cash from operating activities | -$61.7 million | -$49.8 million | 10-K 2023-03-24 · proof | |
| Free cash flow | -$81.6 million | -$59.4 million | 10-K 2023-03-24 · proof | |
| Total assets | $145.6 million | $201.6 million | -27.8% | 10-K 2023-03-24 · proof |
| Total liabilities | $85.1 million | $71.6 million | +18.9% | 10-K 2023-03-24 · proof |
| Cash and cash equivalents | $25.7 million | $100.8 million | -74.5% | 10-K 2023-03-24 · proof |
| Total debt | $39.4 million | $0 | 10-K 2023-03-24 · proof |
- What was Oncorus, Inc.'s operating income in fiscal 2022?
- Oncorus, Inc. reported operating income of -$76.5 million for fiscal 2022 (the year ended Dec 31, 2022), against -$64.8 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What was Oncorus, Inc.'s net income in fiscal 2022?
- Oncorus, Inc. reported net income of -$77.4 million for fiscal 2022 (the year ended Dec 31, 2022), against -$64.8 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What was Oncorus, Inc.'s cash from operating activities in fiscal 2022?
- Oncorus, Inc. reported cash from operating activities of -$61.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$49.8 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What was Oncorus, Inc.'s free cash flow in fiscal 2022?
- Oncorus, Inc. reported free cash flow of -$81.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$59.4 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What are Oncorus, Inc.'s total assets?
- As of Dec 31, 2022, Oncorus, Inc. reported total assets of $145.6 million, against $201.6 million a year earlier (-27.8%). Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What are Oncorus, Inc.'s total liabilities?
- As of Dec 31, 2022, Oncorus, Inc. reported total liabilities of $85.1 million, against $71.6 million a year earlier (+18.9%). Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What are Oncorus, Inc.'s cash and cash equivalents?
- As of Dec 31, 2022, Oncorus, Inc. reported cash and cash equivalents of $25.7 million, against $100.8 million a year earlier (-74.5%). Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
- What is Oncorus, Inc.'s total debt?
- As of Dec 31, 2022, Oncorus, Inc. reported total debt of $39.4 million, against $0 a year earlier. Source: the 10-K filed with the SEC on Mar 24, 2023. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1671818&period_type=annual&limit=5"Information only, not investment advice.